U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT07476586) titled 'A Study to Evaluate the Safety, Tolerability, Pharmacokinetics of GenSci161 in Healthy Adult Participants' on March 12.
Brief Summary: To Evaluate the Safety and Tolerability, Pharmacokinetics and Biomarker of GenSci161 in a Randomized, Double-blind, Placebo-controlled Study in Healthy Adult Participants.
Study Start Date: April 23
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: GenSci161
Administered subcutaneous injection
DRUG: Placebo
Administered subcutaneous injection
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Published by HT Digital C...